SCHEMBL15523762

SCHEMBL15523762

COc1ccc(-c2nnc(NC(=O)c3ccc(Cl)cc3Cl)o2)cc1

nearest known ligand 0.84

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.84
▸ HTT P42858 4/20 0.84
▸ LMNA P02545 3/20 0.84
▸ MEN1 O00255 3/20 0.84
▸ KMT2A Q03164 3/20 0.84
▸ ALDH1A1 P00352 2/20 0.84
▸ MAPT P10636 2/20 0.64
▸ HSP90AA1 P07900 1/20 0.64
▸ TDP1 Q9NUW8 1/20 0.64
▸ CSNK2A2 P19784 1/20 0.60
▸ CSNK2A1 P68400 1/20 0.60
▸ ADCY1 Q08828 3/20 0.59
▸ OPRK1 P41145 1/20 0.59
▸ RECQL P46063 1/20 0.59
▸ CCR6 P51684 1/20 0.59
▸ GSK3B P49841 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ ALOX12 P18054 1/20 0.55
▸ MDM2 Q00987 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17718698 0.91 KDM4E (0.70) KDM4EHTTLMNAMEN1KMT2A
SCHEMBL17717102 0.83 KDM4E (0.65) KDM4EHTTLMNAMEN1KMT2A
SCHEMBL13430346 0.81 CSNK2A2 (0.79) KDM4EHTTLMNAMEN1KMT2A
SCHEMBL1900201 0.80 STAT3 (0.73) KDM4EHTTLMNAMEN1KMT2A
SCHEMBL17716958 0.78 MAPT (1.00) KDM4EHTTLMNAMEN1KMT2A
SCHEMBL24145690 0.78 KDM4E (0.61) KDM4EHTTLMNAMEN1KMT2A
SCHEMBL24145809 0.78 RAB9A (0.60) KDM4EHTTLMNAMEN1KMT2A
SCHEMBL11120915 0.77 KCNH2 (0.76) KDM4EMEN1KMT2AMAPT
SCHEMBL12614530 0.76 KDM4E (0.65) KDM4EHTTLMNAMEN1KMT2A
SCHEMBL17318647 0.76 DDX3X (0.64) KDM4EMEN1KMT2AMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2688885-B1 N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES AND USE THEREOF AS HERBICIDES BAYER IP GMBH (DE) 2016-06-01 — — EP disclosed
US-9101141-B2 N-(1,3,4-oxadiazol-2-yl)arylcarboxamides and use thereof as herbicides BAYER INTERLLECTUAL PROPERTY GMBH (DE) 2015-08-11 — — US disclosed
US-20140080705-A1 N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES AND USE THEREOF AS HERBICIDES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140080705-A1 N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES AND USE THEREOF AS HERBICIDES PRDX4, CBR3, AOX1 KDM4E 1426/4885HTT 1936/4885LMNA 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback